Mr. Vijayabhanu Prattipati

Mr. Vijayabhanu Prattipati has 18 years of strong experience in the formulation research and development in generics and differentiated products. He is heading the R & D of Pleiades Therapeutics Private Limited. He has been instrumental in development and successful delivery of generics products for regulated markets. Mr. Vijayabhanu founded Pleiades Therapeutics and is a managing partner of the company. Prior to Pleiades Therapeutics he has spent more than a decade in Alkem Laboratories, Sun Pharma, and Slayback Pharma. In prior assignment core expertise in handling technical activities of CDMO’s.

Mr. Vijayabhanu has a Masters in Pharmaceutical Technology, holds couple of PCT applications and domestic patents to his credit.

Mr. Amit Joshi

Mr. Amit has more than 16 years of experience in Pharma industry, Medical device and Derma industry. He brings rich experience in Analytical Research and Development including analytical method development, Analytical method validation with demonstrated track record in successful method transfer activities of oral solids and Dermatological formulations.

He also established robust governance processes for quality and compliance in his previous roles, including development and improvement of QMS systems and compliance systems including regulatory audit preparation. He has been instrumental in leading teams across the spectrum of R&D and Compliance functions. He Has worked across the spectrum in companies such as Orchid Chemicals and Pharmaceuticals, Emcure Pharmaceuticals, Wockhardt Research Centre, Johnson and Johnson and Alembic Pharmaceuticals Ltd.

Mr. Amit Has a masters degree in Analytical Chemistry.

Mr. Rambabu Vanam

Mr. Rambabu has over 18 years of experience in pharmaceutical industries. He has expertise in analytical method development and method validations, analytical quality assurance, handling of analytical regulatory queries and quality control in both API and Product Development life cycle management.

He has very good understanding of auditing all facets of the pharmaceutical industry: CGMP (21CFR 210, 211, 21CFR 820) ICH Q7A; He has well versed in defining procedures for qualification, validation, standard operating procedures ("SOPs") design, development and validation of test methods, equipment, processes, and training; materials definition; methods; and systems management.

Mr. Rambabu has a masters in science.